Immunocore Holdings plc ADR [NASDAQ: IMCR] traded at a high on Thursday, posting a 1.94 gain after which it closed the day’ session at $28.41.
The results of the trading session contributed to over 189741 shares changing hands. Over the past one week, the price volatility of Immunocore Holdings plc ADR stands at 5.41% while the volatility over the past one month is 6.12%.
The market cap for IMCR stock reached $1.42 billion, with 50.06 million shares outstanding and 48.69 million shares in the current float. Compared to the average trading volume of 308.65K shares, IMCR reached a trading volume of 189741 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Immunocore Holdings plc ADR [IMCR]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for IMCR shares is $63.84 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on IMCR stock is a recommendation set at 1.71. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Morgan Stanley have made an estimate for Immunocore Holdings plc ADR shares, keeping their opinion on the stock as Equal-Weight, with their previous recommendation back on December 13, 2024. While these analysts kept the previous recommendation, Mizuho dropped their target price from $72 to $38. The new note on the price target was released on November 11, 2024, representing the official price target for Immunocore Holdings plc ADR stock. Previously, the target price had yet another raise to $24, while UBS analysts kept a Sell rating on IMCR stock.
The Average True Range (ATR) for Immunocore Holdings plc ADR is set at 1.68, with the Price to Sales ratio for IMCR stock in the period of the last 12 months amounting to 4.58. The Price to Book ratio for the last quarter was 3.97, with the Price to Cash per share for the same quarter was set at 16.39. Price to Free Cash Flow for IMCR in the course of the last twelve months was 68.05 with Quick ratio for the last quarter at 4.36.
How has IMCR stock performed recently?
Immunocore Holdings plc ADR [IMCR] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 10.03. With this latest performance, IMCR shares dropped by -1.04% in over the last four-week period, additionally sinking by -12.10% over the last 6 months – not to mention a drop of -46.77% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for IMCR stock in for the last two-week period is set at 51.57, with the RSI for the last a single of trading hit 56.05, and the three-weeks RSI is set at 49.70 for Immunocore Holdings plc ADR [IMCR]. The present Moving Average for the last 50 days of trading for this stock 28.92, while it was recorded at 27.42 for the last single week of trading, and 32.34 for the last 200 days.
Immunocore Holdings plc ADR [IMCR]: Deeper insight into the fundamentals
Immunocore Holdings plc ADR’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.36 and a Current Ratio set at 4.38.
Earnings analysis for Immunocore Holdings plc ADR [IMCR]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for IMCR. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Immunocore Holdings plc ADR go to -20.67%.
Insider trade positions for Immunocore Holdings plc ADR [IMCR]
There are presently around $93.91%, or 99.10%% of IMCR stock, in the hands of institutional investors. The top three institutional holders of IMCR stocks are: WELLINGTON MANAGEMENT GROUP LLP with ownership of 6.38 million shares, which is approximately 12.7573%. RTW INVESTMENTS, LP, holding 4.87 million shares of the stock with an approximate value of $$165.04 million in IMCR stocks shares; and RTW INVESTMENTS, LP, currently with $$163.1 million in IMCR stock with ownership which is approximately 9.6225%.
